Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
PLoS One
    January 2022
  1. YU F, Zhou X, Jin X, Zhao S, et al
    Rational construction of controllable autoimmune diabetes model depicting clinical features.
    PLoS One. 2022;17:e0260100.
    >> Share

  2. OKOTH K, Subramanian A, Chandan JS, Adderley NJ, et al
    Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study.
    PLoS One. 2022;17:e0261769.
    >> Share

  3. ARIF B, Arif Z, Ahmad J, Perveen K, et al
    Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
    PLoS One. 2022;17:e0262233.
    >> Share

  4. KALKOWSKI L, Golubczyk D, Kwiatkowska J, Domzalska M, et al
    Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement.
    PLoS One. 2022;17:e0262677.
    >> Share

  5. WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
    Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
    PLoS One. 2022;17:e0262480.
    >> Share

  6. HORTON MK, McCurdy S, Shao X, Bellesis K, et al
    Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
    PLoS One. 2022;17:e0262093.
    >> Share

  7. SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
    Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
    PLoS One. 2022;17:e0262160.
    >> Share

  8. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    >> Share

  9. PETROVA T, Bennett K, Nanda S, Strickson S, et al
    Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
    PLoS One. 2022;17:e0263151.
    >> Share

  10. LERKVALEEKUL B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, et al
    Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    PLoS One. 2022;17:e0263536.
    >> Share

  11. AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
    Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
    PLoS One. 2022;17:e0263606.
    >> Share

  12. ALAZWARI A, Abdollahian M, Tafakori L, Johnstone A, et al
    Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia.
    PLoS One. 2022;17:e0264118.
    >> Share

  13. BEDI S, Richardson TM, Jia B, Saab H, et al
    Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
    PLoS One. 2022;17:e0261103.
    >> Share

  14. TANIGUCHI H, Nirengi S, Ishihara K, Sakane N, et al
    Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0263774.
    >> Share

  15. QUIGLEY M, Earnest A, Szwarcbard N, Wischer N, et al
    Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
    PLoS One. 2022;17:e0263511.
    >> Share

  16. LI JY, Sun XH, Shen DC, Yang XZ, et al
    Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
    PLoS One. 2022;17:e0266529.
    >> Share

  17. MEKONNEN GA, Gelaye KA, Gebreyohannes EA, Abegaz TM, et al
    Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study.
    PLoS One. 2022;17:e0264626.
    >> Share

  18. KONG X, Diao S, Xu H, Sun J, et al
    Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.
    PLoS One. 2022;17:e0266265.
    >> Share

  19. MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
    Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
    PLoS One. 2022;17:e0266203.
    >> Share

  20. QEADAN F, Tingey B, Egbert J, Pezzolesi MG, et al
    The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data.
    PLoS One. 2022;17:e0266809.
    >> Share

  21. MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
    Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266492.
    >> Share

  22. CHEN X, Zhang Y, Luo Z, Wu Y, et al
    Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0264705.
    >> Share

  23. TANA MM, Klepper A, Lyden A, Pisco AO, et al
    Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
    PLoS One. 2022;17:e0264307.
    >> Share

  24. NGAMJANYAPORN P, Worawichawong S, Pisitkun P, Khiewngam K, et al
    Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    PLoS One. 2022;17:e0263778.
    >> Share

  25. CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
    PLoS One. 2022;17:e0264123.
    >> Share

  26. KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
    Do Hungarian multiple sclerosis care units fulfil international criteria?
    PLoS One. 2022;17:e0264328.
    >> Share

  27. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    >> Share

  28. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    >> Share

  29. ROVO A, Cantoni N, Samii K, Rufer A, et al
    Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    PLoS One. 2022;17:e0267342.
    >> Share

  30. FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
    Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    PLoS One. 2022;17:e0264489.
    >> Share

  31. ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
    Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
    PLoS One. 2022;17:e0264708.
    >> Share

  32. LIN X, Liu Y, Chen Y, Huang X, et al
    Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
    PLoS One. 2022;17:e0265017.
    >> Share

  33. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    >> Share

  34. GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
    A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
    PLoS One. 2022;17:e0267245.
    >> Share

  35. RAHIM T, Levinson MA, Carufe KEW, Burak M, et al
    The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.
    PLoS One. 2022;17:e0267913.
    >> Share

  36. ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
    Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
    PLoS One. 2022;17:e0267504.
    >> Share

  37. WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
    Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
    PLoS One. 2022;17:e0266786.
    >> Share

  38. HIERL KV, Krause M, Kruber D, Sterker I, et al
    3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.
    PLoS One. 2022;17:e0265324.
    >> Share

  39. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    >> Share

  40. IIDA M, Ohtomo S, Wada NA, Ueda O, et al
    TNF-alpha induces Claudin-1 expression in renal tubules in Alport mice.
    PLoS One. 2022;17:e0265081.
    >> Share

  41. BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
    A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
    PLoS One. 2022;17:e0268475.
    >> Share

  42. ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
    Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
    PLoS One. 2022;17:e0268125.
    >> Share

  43. KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
    Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
    PLoS One. 2022;17:e0268783.
    >> Share

  44. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    >> Share

  45. COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
    Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
    PLoS One. 2022;17:e0269085.
    >> Share

  46. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    >> Share

  47. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    >> Share

  48. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
    PLoS One. 2022;17:e0269610.
    >> Share

  49. ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
    Optic neuritis: A South African hospital-based prospective study protocol.
    PLoS One. 2022;17:e0269514.
    >> Share

  50. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    >> Share

  51. MAROZOFF S, Mai A, Dehghan N, Sayre EC, et al
    Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.
    PLoS One. 2022;17:e0270142.
    >> Share

  52. HUANG Y, Wang WK, Zheng XM, Yang L, et al
    Decreased salivary alpha-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.
    PLoS One. 2022;17:e0269621.
    >> Share

  53. PETRZALKA M, Meluzinova E, Libertinova J, Mojzisova H, et al
    IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
    PLoS One. 2022;17:e0270607.
    >> Share

  54. ALBURNO H, Mercken L, de Vries H, Al Mohannadi D, et al
    Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study.
    PLoS One. 2022;17:e0270984.
    >> Share

  55. RASKIN E, Achiron A, Zloto O, Neuman R, et al
    Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
    PLoS One. 2022;17:e0264918.
    >> Share

  56. HAYASHI K, Sada KE, Asano Y, Katayama Y, et al
    Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
    PLoS One. 2022;17:e0270569.
    >> Share

  57. KRAUSE A, Lee K, Konig D, Faist M, et al
    Six weeks of whole-body vibration improves fine motor accuracy, functional mobility and quality of life in people with multiple sclerosis.
    PLoS One. 2022;17:e0270698.
    >> Share

  58. AFYOUNI H, Haris B, Syed N, Ahmed I, et al
    Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar.
    PLoS One. 2022;17:e0271182.
    >> Share

  59. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study.
    PLoS One. 2022;17:e0271055.
    >> Share

  60. ZANOTTO T, Rice LA, Sosnoff JJ
    Frailty among people with multiple sclerosis who are wheelchair users.
    PLoS One. 2022;17:e0271688.
    >> Share

  61. SHAH R, Mohammed YN, Koehler TJ, Kaur J, et al
    Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
    PLoS One. 2022;17:e0269466.
    >> Share

  62. BREW-SAM N, Desborough J, Parkinson A, Murugappan K, et al
    A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people.
    PLoS One. 2022;17:e0269925.
    >> Share

  63. LOPEZ ORTEGA JM, Martinez PS, Acevedo-Leon D, Capell NE, et al
    Anti-TSH receptor antibodies (TRAb): Comparison of two third generation automated immunoassays broadly used in clinical laboratories and results interpretation.
    PLoS One. 2022;17:e0270890.
    >> Share

  64. VITTURI BK, Rahmani A, Dini G, Montecucco A, et al
    Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0272156.
    >> Share

  65. UELAND GA, Ernes T, Vonheim Madsen T, Husebye ES, et al
    Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.
    PLoS One. 2022;17:e0272133.
    >> Share

  66. TU H, Li N, Liu W, Fan Z, et al
    Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0269371.
    >> Share

  67. PAPADIMITRIOU E, Boutzios G, Mathioudakis AG, Vlahos NF, et al
    Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0260759.
    >> Share

  68. QIU LNY, Cai SV, Chan D, Hess RS, et al
    Seasonality and geography of diabetes mellitus in United States of America dogs.
    PLoS One. 2022;17:e0272297.
    >> Share

    January 2021
  69. ZUCCHI D, Tani C, Elefante E, Stagnaro C, et al
    Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
    PLoS One. 2021;16:e0245274.
    >> Share

  70. RUIZ-QUINONEZ JA, Guzman-Priego CG, Nolasco-Rosales GA, Tovilla-Zarate CA, et al
    Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
    PLoS One. 2021;16:e0245394.
    >> Share

  71. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    >> Share

  72. KATEWA A, Suto E, Hui J, Heredia J, et al
    The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
    PLoS One. 2021;16:e0244439.
    >> Share

  73. WILLETT K, Khan RS, Dine K, Wessel H, et al
    Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
    PLoS One. 2021;16:e0243862.
    >> Share

  74. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    >> Share

  75. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    >> Share

  76. ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
    Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
    PLoS One. 2021;16:e0245721.
    >> Share

  77. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    >> Share

  78. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    >> Share

  79. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    >> Share

  80. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    >> Share

  81. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    >> Share

  82. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    >> Share

  83. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    >> Share

  84. WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
    The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
    PLoS One. 2021;16:e0247173.
    >> Share

  85. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    >> Share

  86. HE J, Kong D, Yang Z, Guo R, et al
    Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
    PLoS One. 2021;16:e0247662.
    >> Share

  87. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    >> Share

  88. HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
    Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
    PLoS One. 2021;16:e0248937.
    >> Share

  89. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    >> Share

  90. GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
    Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    PLoS One. 2021;16:e0248965.
    >> Share

  91. WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
    Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
    PLoS One. 2021;16:e0247501.
    >> Share

  92. KIM SE, Kim J, Lee JY, Lee SB, et al
    Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
    PLoS One. 2021;16:e0249988.
    >> Share

  93. DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
    Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249611.
    >> Share

  94. MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
    Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    PLoS One. 2021;16:e0249592.
    >> Share

  95. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    >> Share

  96. ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
    Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
    PLoS One. 2021;16:e0247052.
    >> Share

  97. CHOI S, Spini M, Hua J, Harrison DM, et al
    Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2021;16:e0249973.
    >> Share

  98. LUU T, Cheung JF, Baccon J, Waldner H, et al
    Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2021;16:e0250340.
    >> Share

  99. SAKUNRANGSIT N, Metheepakornchai P, Kumpunya S, Greenblatt MB, et al
    Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model.
    PLoS One. 2021;16:e0250215.
    >> Share

  100. LIU GY, Wu Y, Kong FY, Ma S, et al
    BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.
    PLoS One. 2021;16:e0243014.
    >> Share

  101. SATITPITAKUL V, Rattanaphong T, Pruksakorn V
    Meibomian glands dropout in patients with inactive thyroid related orbitopathy.
    PLoS One. 2021;16:e0250617.
    >> Share

  102. STERNBACH S, West N, Singhal NK, Clements R, et al
    The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
    PLoS One. 2021;16:e0250486.
    >> Share

  103. GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
    Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
    PLoS One. 2021;16:e0250647.
    >> Share

  104. ALKHATEEB H, El Fathi A, Ghanbari M, Haidar A, et al
    Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
    PLoS One. 2021;16:e0248280.
    >> Share

  105. SENDIC S, Mansouri L, Lundberg S, Nopp A, et al
    B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
    PLoS One. 2021;16:e0248056.
    >> Share

  106. SHAHARIR SS, Chua SH, Mohd R, Mustafar R, et al
    Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
    PLoS One. 2021;16:e0248845.
    >> Share

  107. CANDADAI AA, Liu F, Fouda AY, Alfarhan M, et al
    Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis.
    PLoS One. 2021;16:e0247901.
    >> Share

  108. IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
    Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
    PLoS One. 2021;16:e0248549.
    >> Share

  109. WILSKI M, Brola W, Luniewska M, Tomczak M, et al
    The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
    PLoS One. 2021;16:e0248135.
    >> Share

  110. SATO H, Ichikawa D, Okada E, Suzuki T, et al
    Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    PLoS One. 2021;16:e0251294.
    >> Share

  111. LU Z, Liu W, Gao H, Chen W, et al
    Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251131.
    >> Share

  112. FATOYE F, Gebrye T, Svenson LW
    Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    PLoS One. 2021;16:e0251409.
    >> Share

  113. LIAO K, Chen K, Brett S, Gehman A, et al
    Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
    PLoS One. 2021;16:e0249049.
    >> Share

  114. CHARNIGA K, Cucunuba ZM, Walteros DM, Mercado M, et al
    Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017.
    PLoS One. 2021;16:e0252236.
    >> Share

  115. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    >> Share

  116. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    >> Share

  117. STOUGAARD EB, Winther SA, Amadid H, Frimodt-Moller M, et al
    Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
    PLoS One. 2021;16:e0254859.
    >> Share

  118. MECA-LALLANA JE, Maurino J, Perez-Miralles F, Forero L, et al
    Quantifying the patient s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
    PLoS One. 2021;16:e0255317.
    >> Share

  119. NEGASH Z, Berha AB, Shibeshi W, Ahmed A, et al
    Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0251709.
    >> Share

  120. HOFFMAN WH, Whelan SA, Lee N
    Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
    PLoS One. 2021;16:e0254116.
    >> Share

  121. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2021;16:e0257809.
    >> Share

  122. SWANN JW, Tayler S, Hall H, Sparrow R, et al
    Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
    PLoS One. 2021;16:e0257700.
    >> Share

  123. MCCALL JL, Blair HC, Blethen KE, Hall C, et al
    Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.
    PLoS One. 2021;16:e0249442.
    >> Share

  124. GAJ S, Ontaneda D, Nakamura K
    Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
    PLoS One. 2021;16:e0255939.
    >> Share

  125. KIRILMAZ OB, Salegaonkar AR, Shiau J, Uzun G, et al
    Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    PLoS One. 2021;16:e0254718.
    >> Share

  126. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
    PLoS One. 2021;16:e0254226.
    >> Share

  127. JOHNSON M, Ehlers S, Fernell E, Hajjari P, et al
    Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review.
    PLoS One. 2021;16:e0253844.
    >> Share

  128. BRATT G, Brannstrom J, Missalidis C, Nystrom T, et al
    Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
    PLoS One. 2021;16:e0254079.
    >> Share

  129. NGUYEN THP, Fagerland MW, Deyab G, Hjeltnes G, et al
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    PLoS One. 2021;16:e0253793.
    >> Share

  130. FAGBAMIGBE AF, Norrman E, Bergh C, Wennerholm UB, et al
    Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.
    PLoS One. 2021;16:e0253389.
    >> Share

  131. VAN DOORN WPTM, Foreman YD, Schaper NC, Savelberg HHCM, et al
    Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
    PLoS One. 2021;16:e0253125.
    >> Share

  132. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    >> Share

  133. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    >> Share

  134. WYSOCKA-MINCEWICZ M, Golebiewska J, Baszynska-Wilk M, Olechowski A, et al
    Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes.
    PLoS One. 2021;16:e0252588.
    >> Share

  135. WORAWICHAWONG S, Plumworasawat S, Liwlompaisan W, Sumethkul V, et al
    Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy.
    PLoS One. 2021;16:e0252638.
    >> Share

  136. PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
    Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
    PLoS One. 2021;16:e0250820.
    >> Share

  137. ROZYCKA J
    How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
    PLoS One. 2021;16:e0258740.
    >> Share

  138. PARIKH RV, Tan TC, Fan D, Law D, et al
    Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    PLoS One. 2021;16:e0257674.
    >> Share

  139. MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
    Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
    PLoS One. 2021;16:e0258017.
    >> Share

  140. NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
    The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256845.
    >> Share

  141. SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
    Multiple sclerosis reduces synchrony of the magnocellular pathway.
    PLoS One. 2021;16:e0255324.
    >> Share

  142. JANG SY, Choi SH, Kikkawa D, Lee EJ, et al
    Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    PLoS One. 2021;16:e0255344.
    >> Share

  143. GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
    Genetic susceptibility to multiple sclerosis in African Americans.
    PLoS One. 2021;16:e0254945.
    >> Share

  144. SIDDIG O, Mustafa MB, Kordofani Y, Gibson J, et al
    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
    PLoS One. 2021;16:e0254634.
    >> Share

  145. MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
    Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
    PLoS One. 2021;16:e0258437.
    >> Share

  146. TEZUKA Y, Eguchi-Ishimae M, Ozaki E, Ito T, et al
    Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    PLoS One. 2021;16:e0258090.
    >> Share

  147. LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
    Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    PLoS One. 2021;16:e0253337.
    >> Share

  148. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    >> Share

  149. KIM SS, Hudgins AD, Yang J, Zhu Y, et al
    A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    PLoS One. 2021;16:e0257265.
    >> Share

  150. OSAKI T, Souri M, Ichinose A
    Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
    PLoS One. 2021;16:e0257322.
    >> Share

  151. AHMAD I, Wergeland S, Oveland E, Bo L, et al
    A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    PLoS One. 2021;16:e0256155.
    >> Share

  152. NATHAN DM, Krause-Steinrauf H, Braffett BH, Arends VL, et al
    Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.
    PLoS One. 2021;16:e0257154.
    >> Share

  153. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    >> Share

  154. ALKETBI A, Basit S, Hamza N, Walton LM, et al
    The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    PLoS One. 2021;16:e0258752.
    >> Share

  155. PARUNYAKUL K, Srisuksai K, Charoenlappanit S, Phaonakrop N, et al
    Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2021;16:e0256140.
    >> Share

  156. SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
    Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    PLoS One. 2021;16:e0261050.
    >> Share

  157. VALORI M, Jansson L, Tienari PJ
    CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
    PLoS One. 2021;16:e0261002.
    >> Share

  158. ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
    Bacterial variation in the oral microbiota in multiple sclerosis patients.
    PLoS One. 2021;16:e0260384.
    >> Share

  159. RENAUD A, Caristan A, Seguin A, Agard C, et al
    Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.
    PLoS One. 2021;16:e0260196.
    >> Share

  160. BOCH K, Drager S, Zillikens D, Hudemann C, et al
    Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
    PLoS One. 2021;16:e0259586.
    >> Share

  161. HSU CY, Chueh YS, Kuo ML, Lee PT, et al
    Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
    PLoS One. 2021;16:e0261727.
    >> Share

  162. BLUTHGEN C, Patella M, Euler A, Baessler B, et al
    Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis.
    PLoS One. 2021;16:e0261401.
    >> Share

  163. COOLEN M, Broadley M, Hendrieckx C, Chatwin H, et al
    The impact of hypoglycemia on quality of life and related outcomes in children and adolescents with type 1 diabetes: A systematic review.
    PLoS One. 2021;16:e0260896.
    >> Share

  164. MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
    Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    PLoS One. 2021;16:e0261097.
    >> Share

  165. MANUWALD U, Schoffer O, Kugler J, Riemenschneider H, et al
    Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany.
    PLoS One. 2021;16:e0262171.
    >> Share

  166. CAREY IM, Banchoff E, Nirmalananthan N, Harris T, et al
    Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
    PLoS One. 2021;16:e0261983.
    >> Share

  167. MIDTHASSEL TC, Hansen AH
    Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.
    PLoS One. 2021;16:e0261471.
    >> Share

    January 2020
  168. LI Z, Rotival M, Patin E, Michel F, et al
    Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
    PLoS One. 2020;15:e0225289.
    >> Share

  169. MATSUOKA N, Fujita Y, Temmoku J, Furuya MY, et al
    Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
    PLoS One. 2020;15:e0227069.
    >> Share

  170. JANG S, Kim JH, Choi SY, Park SJ, et al
    Application of computerized 3D-CT texture analysis of pancreas for the assessment of patients with diabetes.
    PLoS One. 2020;15:e0227492.
    >> Share

  171. PLAZINSKA MT, Sawicka-Gutaj N, Czarnywojtek A, Wolinski K, et al
    Radioiodine therapy and Graves' disease - Myths and reality.
    PLoS One. 2020;15:e0226495.
    >> Share

  172. OGAWA-AKIYAMA A, Sugiyama H, Kitagawa M, Tanaka K, et al
    Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
    PLoS One. 2020;15:e0228337.
    >> Share

  173. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    >> Share

  174. AHMED CM, Ildefonso CJ, Johnson HM, Lewin AS, et al
    A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis.
    PLoS One. 2020;15:e0227524.
    >> Share

  175. CHEWCHARAT A, Chewcharat P, Rutirapong A, Papatheodorou S, et al
    The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0228315.
    >> Share

  176. PELLEGRINO M, Traversi G, Arena A, Cappa M, et al
    Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients.
    PLoS One. 2020;15:e0228296.
    >> Share

  177. PENG YH, Lin YS, Chen CH, Tsai KY, et al
    Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
    PLoS One. 2020;15:e0226997.
    >> Share

  178. HOSONUMA M, Yajima N, Takahashi R, Yanai R, et al
    Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity.
    PLoS One. 2020;15:e0227022.
    >> Share

  179. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    >> Share

  180. GOLDMAN MD, Dwyer L, Coleman R, Sohn MW, et al
    Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
    PLoS One. 2020;15:e0228617.
    >> Share

  181. HJORTH M, Dandu N, Mellergard J
    Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    PLoS One. 2020;15:e0228380.
    >> Share

  182. GRANER M, Pointon T, Manton S, Green M, et al
    Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
    PLoS One. 2020;15:e0228883.
    >> Share

  183. ZWINGLI G, Yerly J, Mivelaz Y, Stoppa-Vaucher S, et al
    Non-invasive assessment of coronary endothelial function in children and adolescents with type 1 diabetes mellitus using isometric handgrip exercise-MRI: A feasibility study.
    PLoS One. 2020;15:e0228569.
    >> Share

  184. GIOVANNETTI AM, Pietrolongo E, Borreani C, Giordano A, et al
    Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.
    PLoS One. 2020;15:e0228587.
    >> Share

  185. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    >> Share

  186. AUNGSUMART S, Apiwattanakul M
    Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    PLoS One. 2020;15:e0229028.
    >> Share

  187. YALACHKOV Y, Uhlmann V, Bergmann J, Soydas D, et al
    Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance.
    PLoS One. 2020;15:e0228679.
    >> Share

  188. BRANT EJ, Rietman EA, Klement GL, Cavaglia M, et al
    Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks.
    PLoS One. 2020;15:e0226883.
    >> Share

  189. EVERS J, Grotenhuis AJ, Aben KKH, Kiemeney LALM, et al
    No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
    PLoS One. 2020;15:e0229384.
    >> Share

  190. SAGAR D, Gaddipati R, Ongstad EL, Bhagroo N, et al
    LOX-1: A potential driver of cardiovascular risk in SLE patients.
    PLoS One. 2020;15:e0229184.
    >> Share

  191. JULIAN GS, Rosim RP, Carneseca EC, Rigolon J, et al
    Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.
    PLoS One. 2020;15:e0229768.
    >> Share

  192. GONGORA-RIVERA F, Grijalva I, Infante-Valenzuela A, Camara-Lemarroy C, et al
    Zika Virus infection and Guillain-Barre syndrome in Northeastern Mexico: A case-control study.
    PLoS One. 2020;15:e0230132.
    >> Share

  193. RAMESH J, Parthasarathy LK, Janckila AJ, Begum F, et al
    Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia.
    PLoS One. 2020;15:e0230052.
    >> Share

  194. MASTRACCI TL, Colvin SC, Padgett LR, Mirmira RG, et al
    Hypusinated eIF5A is expressed in the pancreas and spleen of individuals with type 1 and type 2 diabetes.
    PLoS One. 2020;15:e0230627.
    >> Share

  195. SECCIA R, Gammelli D, Dominici F, Romano S, et al
    Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis.
    PLoS One. 2020;15:e0230219.
    >> Share

  196. NOWLING TK, Rodgers J, Thiyagarajan T, Wolf B, et al
    Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    PLoS One. 2020;15:e0230499.
    >> Share

  197. MORIKAWA M, Kato-Hirayama E, Mayama M, Saito Y, et al
    Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy.
    PLoS One. 2020;15:e0230488.
    >> Share

  198. SELGRADE BP, Meyer D, Sosnoff JJ, Franz JR, et al
    Can optical flow perturbations detect walking balance impairment in people with multiple sclerosis?
    PLoS One. 2020;15:e0230202.
    >> Share

  199. SILVA T, Fragoso YD, Destro Rodrigues MFS, Gomes AO, et al
    Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis - Randomized clinical trial.
    PLoS One. 2020;15:e0230551.
    >> Share

  200. MASUDA H, Mori M, Uzawa A, Uchida T, et al
    Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    PLoS One. 2020;15:e0224419.
    >> Share

  201. FOOLAD F, Khodagholi F, Nabavi SM, Javan M, et al
    Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities.
    PLoS One. 2020;15:e0230691.
    >> Share

  202. SAURI-SUAREZ S, Quinones-Aguilar S, Contreras-Marin A, Ramiro-Guerrero EO, et al
    Adherence to self-administering interferon-beta1a using RebiSmart(R) device in Mexican patients with relapsing multiple sclerosis.
    PLoS One. 2020;15:e0230959.
    >> Share

  203. POLSKY S, Garcetti R, Pyle L, Joshee P, et al
    Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    PLoS One. 2020;15:e0230476.
    >> Share

  204. GIOVANNETTI AM, Quintas R, Tramacere I, Giordano A, et al
    A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study.
    PLoS One. 2020;15:e0231380.
    >> Share

  205. HASHEMI R, Hosseini-Asl SS, Arefhosseini SR, Morshedi M, et al
    The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives.
    PLoS One. 2020;15:e0231145.
    >> Share

  206. NINOU I, Sevastou I, Magkrioti C, Kaffe E, et al
    Genetic deletion of Autotaxin from CD11b+ cells decreases the severity of experimental autoimmune encephalomyelitis.
    PLoS One. 2020;15:e0226050.
    >> Share

  207. PARRAVICINI C, Lecca D, Marangon D, Coppolino GT, et al
    Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis.
    PLoS One. 2020;15:e0231483.
    >> Share

  208. ZHANG X, Liu L, Ma X, Hu W, et al
    Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE.
    PLoS One. 2020;15:e0231622.
    >> Share

  209. MANNERING N, Hansen DL, Frederiksen H
    Evans syndrome in children below 13 years of age - A nationwide population-based cohort study.
    PLoS One. 2020;15:e0231284.
    >> Share

  210. AKAISHI T, Takahashi T, Fujihara K, Misu T, et al
    Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
    PLoS One. 2020;15:e0231225.
    >> Share

  211. GORDON RA, Tilstra JS, Marinov A, Nickerson KM, et al
    Murine lupus is neutrophil elastase-independent in the MRL.Faslpr model.
    PLoS One. 2020;15:e0226396.
    >> Share

  212. BARRERO F, Mallada-Frechin J, Martinez-Gines ML, Marzo ME, et al
    Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
    PLoS One. 2020;15:e0230846.
    >> Share

  213. OHLMEIER C, Gothe H, Haas J, Osowski U, et al
    Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
    PLoS One. 2020;15:e0231846.
    >> Share

  214. SUGIYAMA M, Wada Y, Kanazawa N, Tachibana S, et al
    A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schonlein purpura nephritis and IgA nephropathy.
    PLoS One. 2020;15:e0232194.
    >> Share

  215. GOITIA B, Bruno D, Abrevaya S, Sedeno L, et al
    The relationship between executive functions and fluid intelligence in multiple sclerosis.
    PLoS One. 2020;15:e0231868.
    >> Share

  216. VAN DE KREEKE JA, Darma S, Chan Pin Yin JMPL, Tan HS, et al
    The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy.
    PLoS One. 2020;15:e0231552.
    >> Share

  217. ABREGO-PEREDO A, Romero-Ramirez H, Espinosa E, Lopez-Herrera G, et al
    Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile.
    PLoS One. 2020;15:e0233138.
    >> Share

  218. HOLTE KB, Svanteson M, Hanssen KF, Sveen KA, et al
    Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study.
    PLoS One. 2020;15:e0233174.
    >> Share

  219. KIM SH, Rhee Y, Kim YM, Won YJ, et al
    Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study.
    PLoS One. 2020;15:e0232842.
    >> Share

  220. KATAOKA H, Ohara M, Suzuki T, Inoue T, et al
    Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    PLoS One. 2020;15:e0232885.
    >> Share

  221. LUCCHETTA RC, Leonart LP, Goncalves MVM, Becker J, et al
    Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2020;15:e0231722.
    >> Share

  222. BROWN FS, Glasmacher SA, Kearns PKA, MacDougall N, et al
    Systematic review of prediction models in relapsing remitting multiple sclerosis.
    PLoS One. 2020;15:e0233575.
    >> Share

  223. VAN JAD, Clotet-Freixas S, Hauschild AC, Batruch I, et al
    Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetes.
    PLoS One. 2020;15:e0233639.
    >> Share

  224. SAKONO T, Meguro A, Takeuchi M, Yamane T, et al
    Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
    PLoS One. 2020;15:e0233464.
    >> Share

  225. KUSNIEROVA P, Zeman D, Hradilek P, Zapletalova O, et al
    Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    PLoS One. 2020;15:e0233519.
    >> Share

  226. PAMPHLETT R, Mak R, Lee J, Buckland ME, et al
    Concentrations of toxic metals and essential trace elements vary among individual neurons in the human locus ceruleus.
    PLoS One. 2020;15:e0233300.
    >> Share

  227. IMAI E, Usui J, Kaneko S, Kawamura T, et al
    The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies.
    PLoS One. 2020;15:e0233186.
    >> Share

  228. GILLEY KN, Wierenga KA, Chauhuan PS, Wagner JG, et al
    Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice.
    PLoS One. 2020;15:e0233183.
    >> Share

  229. MURATA T, Kyozuka H, Fukuda T, Yasuda S, et al
    Risk of adverse obstetric outcomes in Japanese women with systemic lupus erythematosus: The Japan Environment and Children's Study.
    PLoS One. 2020;15:e0233883.
    >> Share

  230. BHATIA SM, Streilein RD, Hall RP
    Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    PLoS One. 2020;15:e0233957.
    >> Share

  231. BAUER A, Lechner I, Auer M, Berger T, et al
    Influence of physical activity on serum vitamin D levels in people with multiple sclerosis.
    PLoS One. 2020;15:e0234333.
    >> Share

  232. MORKHOLT AS, Oklinski MK, Larsen A, Bockermann R, et al
    Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
    PLoS One. 2020;15:e0234493.
    >> Share

  233. MORALES PANTOJA IE, Smith MD, Rajbhandari L, Cheng L, et al
    iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu.
    PLoS One. 2020;15:e0233980.
    >> Share

  234. VIAR K, Njoku D, Secor McVoy J, Oh U, et al
    Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
    PLoS One. 2020;15:e0235110.
    >> Share

  235. JI H, Godsland I, Oliver NS, Hill NE, et al
    Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes.
    PLoS One. 2020;15:e0234319.
    >> Share

  236. KEMMERER CL, Pernpeintner V, Ruschil C, Abdelhak A, et al
    Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
    PLoS One. 2020;15:e0235449.
    >> Share

  237. CHERAGHMAKANI H, Baghbanian SM, HabibiSaravi R, Azar A, et al
    Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.
    PLoS One. 2020;15:e0235562.
    >> Share

  238. JIANG K, Kessler H, Park Y, Sudman M, et al
    Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.
    PLoS One. 2020;15:e0235857.
    >> Share

  239. JEON HS, Lee SM, Jung YM, Oh S, et al
    Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.
    PLoS One. 2020;15:e0235838.
    >> Share

  240. VON BORSTEL A, Abdulahad WH, Dekkema G, Rutgers A, et al
    Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    PLoS One. 2020;15:e0235743.
    >> Share

  241. ROTSTEIN DL, Marrie RA, Tu K, Schultz SE, et al
    Health service utilization in immigrants with multiple sclerosis.
    PLoS One. 2020;15:e0234876.
    >> Share

  242. ILJICSOV A, Milanovich D, Ajtay A, Oberfrank F, et al
    Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
    PLoS One. 2020;15:e0236432.
    >> Share

  243. FARCI R, Carta A, Cocco E, Frau J, et al
    Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study.
    PLoS One. 2020;15:e0236090.
    >> Share

  244. MALDINEY T, Greigert H, Martin L, Benoit E, et al
    Full-field optical coherence tomography for the diagnosis of giant cell arteritis.
    PLoS One. 2020;15:e0234165.
    >> Share

  245. ZHAI Y, Liu Y, Qi Y, Long X, et al
    The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy.
    PLoS One. 2020;15:e0234492.
    >> Share

  246. CAVERZASI E, Cordano C, Zhu AH, Zhao C, et al
    Imaging correlates of visual function in multiple sclerosis.
    PLoS One. 2020;15:e0235615.
    >> Share

  247. CHEN CH, Wu MJ, Wen MC, Tsai SF, et al
    Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy.
    PLoS One. 2020;15:e0237075.
    >> Share

  248. MANION KP, Baglaenko Y, Chang NH, Talaei N, et al
    Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in Vkappa8/3H9 lupus-prone mice.
    PLoS One. 2020;15:e0236664.
    >> Share

  249. MARCHINI GS, Cestari IN, Salemi VMC, Irigoyen MC, et al
    Early changes in myocyte contractility and cardiac function in streptozotocin-induced type 1 diabetes in rats.
    PLoS One. 2020;15:e0237305.
    >> Share

  250. BRIX N, Rosthoj S, Glerup M, Hasle H, et al
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.
    PLoS One. 2020;15:e0237530.
    >> Share

  251. BYEON HJ, Kim JY, Ko J, Lee EJ, et al
    Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    PLoS One. 2020;15:e0237015.
    >> Share

  252. OPARA CN, Akintorin M, Byrd A, Cirignani N, et al
    Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g.
    PLoS One. 2020;15:e0236639.
    >> Share

  253. COBO-CALVO A, Ruiz A, Richard C, Blondel S, et al
    Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
    PLoS One. 2020;15:e0238301.
    >> Share

  254. SINHA S, Renavikar PS, Crawford MP, Steward-Tharp SM, et al
    Altered expression of SIRPgamma on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells.
    PLoS One. 2020;15:e0238070.
    >> Share

  255. ALTAMIRANO-BUSTAMANTE NF, Garrido-Magana E, Moran E, Calderon A, et al
    Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early beta-cell damage in obesity and diabetes.
    PLoS One. 2020;15:e0237667.
    >> Share

  256. REED JC, Preston-Hurlburt P, Philbrick W, Betancur G, et al
    The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling.
    PLoS One. 2020;15:e0236921.
    >> Share

  257. DEWAN K, Berke GS, Chhetri DK
    Lessons learned from open laryngotracheal airway resection and primary anastomosis in high risk patients.
    PLoS One. 2020;15:e0238426.
    >> Share

  258. SOUZA KM, Diniz IM, Lemos LLP, Junior NGR, et al
    Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
    PLoS One. 2020;15:e0238476.
    >> Share

  259. ZVIZDIC Z, Kovacevic A, Milisic E, Jonuzi A, et al
    Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country.
    PLoS One. 2020;15:e0237016.
    >> Share

  260. CUBILLOS-ANGULO JM, Vinhaes CL, Fukutani ER, Albuquerque VVS, et al
    In silico transcriptional analysis of mRNA and miRNA reveals unique biosignatures that characterizes different types of diabetes.
    PLoS One. 2020;15:e0239061.
    >> Share

  261. RADWAN S, Gilfillan D, Eklund B, Radwan HM, et al
    A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
    PLoS One. 2020;15:e0238764.
    >> Share

  262. ALNAJASHI H, Jabbad R
    Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.
    PLoS One. 2020;15:e0241103.
    >> Share

  263. BEREK K, Hegen H, Auer M, Zinganell A, et al
    Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi.
    PLoS One. 2020;15:e0239453.
    >> Share

  264. MOSER O, Mueller A, Eckstein ML, Ziko H, et al
    Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
    PLoS One. 2020;15:e0239091.
    >> Share

  265. OSINSKI M, Mantaj U, Kedzia M, Gutaj P, et al
    Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus.
    PLoS One. 2020;15:e0237843.
    >> Share

  266. YOSHIDA M, Kondo K, Matsui N, Izumi Y, et al
    Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients.
    PLoS One. 2020;15:e0239756.
    >> Share

  267. POHLMANN D, Barth A, Macedo S, Pleyer U, et al
    The impact of impending / onset of vision loss on depression, anxiety, and vision-related quality of life in Birdshot-Retinochoroiditis and Serpiginous Choroiditis.
    PLoS One. 2020;15:e0239210.
    >> Share

  268. ONG JX, Kwan CC, Cicinelli MV, Fawzi AA, et al
    Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy.
    PLoS One. 2020;15:e0240064.
    >> Share

  269. HUANG SK, Huang CY, Lin CH, Cheng BW, et al
    Acute kidney injury is a common complication in children and adolescents hospitalized for diabetic ketoacidosis.
    PLoS One. 2020;15:e0239160.
    >> Share

  270. VAIDYA A, Kakizaki H, Takahashi Y
    Changes in horizontal strabismus after inferior rectus muscle recession with or without nasal transposition in thyroid eye disease: A retrospective, observational study.
    PLoS One. 2020;15:e0240019.
    >> Share

  271. DHAOUADI T, Abdellatif J, Trabelsi R, Gaied H, et al
    PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
    PLoS One. 2020;15:e0240025.
    >> Share

  272. NEVES PDMM, Souza RA, Torres FM, Reis FA, et al
    Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.
    PLoS One. 2020;15:e0233199.
    >> Share

  273. MELNIKOV M, Sharanova S, Sviridova A, Rogovskii V, et al
    The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
    PLoS One. 2020;15:e0240305.
    >> Share

  274. D'ALMEIDA OC, Violante IR, Quendera B, Moreno C, et al
    The neurometabolic profiles of GABA and Glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes.
    PLoS One. 2020;15:e0240907.
    >> Share

  275. KUEHN JC, Meschede C, Helmstaedter C, Surges R, et al
    Adult-onset temporal lobe epilepsy suspicious for autoimmune pathogenesis: Autoantibody prevalence and clinical correlates.
    PLoS One. 2020;15:e0241289.
    >> Share

  276. PERLEJEWSKI K, Bukowska-Osko I, Rydzanicz M, Dzieciatkowski T, et al
    Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics.
    PLoS One. 2020;15:e0240601.
    >> Share

  277. LIU L, Wang R, Ding H, Tian L, et al
    The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
    PLoS One. 2020;15:e0240942.
    >> Share

  278. BORCHERT C, Herman A, Roth M, Brooks AC, et al
    RNA sequencing of whole blood in dogs with primary immune-mediated hemolytic anemia (IMHA) reveals novel insights into disease pathogenesis.
    PLoS One. 2020;15:e0240975.
    >> Share

  279. THOMSEN H, Li X, Sundquist K, Sundquist J, et al
    Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
    PLoS One. 2020;15:e0240794.
    >> Share

  280. COTTRELL L, Economos G, Evans C, Silber E, et al
    A realist review of advance care planning for people with multiple sclerosis and their families.
    PLoS One. 2020;15:e0240815.
    >> Share

  281. CHOI JY, Chin HJ, Lee H, Bae EH, et al
    Idiopathic membranous nephropathy in older patients: Clinical features and outcomes.
    PLoS One. 2020;15:e0240566.
    >> Share

  282. MOCHIZUKI M, Ito Y, Yokomichi H, Kikuchi T, et al
    Increasing secular trends in height and obesity in children with type 1 diabetes: JSGIT cohort.
    PLoS One. 2020;15:e0242259.
    >> Share

  283. GROHOVA A, Danova K, Adkins I, Sumnik Z, et al
    Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.
    PLoS One. 2020;15:e0242092.
    >> Share

  284. CORTEZ FJ, Gebhart D, Robinson PV, Seftel D, et al
    Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.
    PLoS One. 2020;15:e0242049.
    >> Share

  285. ZHANG X, Gao B, Xu B
    No association between the vitamin D-binding protein (DBP) gene polymorphisms (rs7041 and rs4588) and multiple sclerosis and type 1 diabetes mellitus: A meta-analysis.
    PLoS One. 2020;15:e0242256.
    >> Share

  286. KASHIWAKURA JI, Saitoh K, Ihara T, Sasaki Y, et al
    Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.
    PLoS One. 2020;15:e0241440.
    >> Share

  287. ABE K, Fujita M, Hayashi M, Takahashi A, et al
    Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.
    PLoS One. 2020;15:e0239481.
    >> Share

  288. AMADOU C, Denis P, Cosker K, Fagot-Campagna A, et al
    Less amputations for diabetic foot ulcer from 2008 to 2014, hospital management improved but substantial progress is still possible: A French nationwide study.
    PLoS One. 2020;15:e0242524.
    >> Share

  289. PERRAUDIN C, Bourdin A, Vicino A, Kuntzer T, et al
    Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
    PLoS One. 2020;15:e0242630.
    >> Share

  290. BASUALTO-ALARCON C, Urra FA, Bozan MF, Jana F, et al
    Idiopathic inflammatory myopathy human derived cells retain their ability to increase mitochondrial function.
    PLoS One. 2020;15:e0242443.
    >> Share

  291. MIGITA K, Nakamura M, Aiba Y, Kozuru H, et al
    Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
    PLoS One. 2020;15:e0238540.
    >> Share

  292. NIKOLIC B, Ivancevic N, Zaletel I, Rovcanin B, et al
    Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
    PLoS One. 2020;15:e0243031.
    >> Share

  293. DING M, Markon A, Wolpert B, Chavarro JE, et al
    Associations of body mass index and waist circumference with risk of Guillain-Barre syndrome in women and men: A prospective analysis of three cohort studies.
    PLoS One. 2020;15:e0239099.
    >> Share

  294. VICKARYOUS N, Jitlal M, Jacobs BM, Middleton R, et al
    Remote testing of vitamin D levels across the UK MS population-A case control study.
    PLoS One. 2020;15:e0241459.
    >> Share

  295. AFAA TJ, Amegan-Aho KH, Dono MT, Odei E, et al
    Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa.
    PLoS One. 2020;15:e0239964.
    >> Share

  296. SMAOUI MR, Rabasa-Lhoret R, Haidar A
    Development platform for artificial pancreas algorithms.
    PLoS One. 2020;15:e0243139.
    >> Share

  297. FREITAS DA, Souza-Santos R, Carvalho LMA, Barros WB, et al
    Congenital Zika syndrome: A systematic review.
    PLoS One. 2020;15:e0242367.
    >> Share

  298. CORDON B, Vilades E, Orduna E, Satue M, et al
    Angiography with optical coherence tomography as a biomarker in multiple sclerosis.
    PLoS One. 2020;15:e0243236.
    >> Share

  299. TANAKA H, Yamaguchi M, Katsuno T, Sugiyama H, et al
    Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.
    PLoS One. 2020;15:e0243572.
    >> Share

  300. ZOPPINI G, Bergamini C, Trombetta M, Mantovani A, et al
    Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes.
    PLoS One. 2020;15:e0244483.
    >> Share

    January 2019
  301. BURKILL S, Vattulainen P, Geissbuehler Y, Sabido Espin M, et al
    The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
    PLoS One. 2019;14:e0227120.
    >> Share

  302. PAN X, Kaminga AC, Wen SW, Acheampong K, et al
    Omentin-1 in diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226292.
    >> Share

  303. CORTINI A, Bembich S, Marson L, Cocco E, et al
    Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.
    PLoS One. 2019;14:e0226162.
    >> Share

  304. HAMMAD SM, Hardin JR, Wilson DA, Twal WO, et al
    Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    PLoS One. 2019;14:e0224496.
    >> Share

  305. CECCARELLI F, Pirone C, Mina C, Mascolo A, et al
    Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    PLoS One. 2019;14:e0224437.
    >> Share

  306. POSTIGO-ALONSO B, Galvao-Carmona A, Conde-Gavilan C, Jover A, et al
    The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls.
    PLoS One. 2019;14:e0226775.
    >> Share

  307. MELIS M, Littera R, Cocco E, Frau J, et al
    Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
    PLoS One. 2019;14:e0226615.
    >> Share

  308. EHLING R, Amprosi M, Kremmel B, Bsteh G, et al
    Second language learning induces grey matter volume increase in people with multiple sclerosis.
    PLoS One. 2019;14:e0226525.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016